Scholar Rock Holding Corp (NASDAQ:SRRK)

5.36
Delayed Data
As of Jul 01
 -0.13 / -2.37%
Today’s Change
4.33
Today|||52-Week Range
44.95
-78.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$306.4M

Company Description

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The firm offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Contact Information

Scholar Rock Holding Corp.
301 Binney Street
Cambridge Massachusetts 02142
P:(857) 259-3860
Investor Relations:

Employees

Shareholders

Other institutional54.85%
Mutual fund holders52.98%
Individual stakeholders47.35%

Top Executives

Nagesh K. MahanthappaPresident, Chief Executive Officer & Director
Edward H. MylesChief Financial Officer & Head-Business Operations
Gregory J. CarvenChief Scientific Officer
George G NomikosSVP-Medical & Clinical Science
Erin MooreSenior Vice President-Finance